Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by Accountprinceon Jan 23, 2023 5:02pm
246 Views
Post# 35240809

Dialco Loss of 70% "Not Material"

Dialco Loss of 70% "Not Material"Has anyone heard anything more from either Spectral or the regulators on this?  This non-disclosure of a material event still stings.  I did go to Sedar to see how often they issued separate news releases related to our investment in Dialco.  Since 2018 there are quite a few of these along with Dialco prominently discussed in most news releases.  Doesn't have the appearance of being a non-material asset over the last five years.

Also, in Feb 2020  Paradigm ascribed a value of $147.633 million to the Dialysis investment which even today is around $0.50 per Spectral share.  For a company trading at $0.385 per share I would consider that material.

Has Spectral provided anyone with any real evidence to back up their assertion that Dialco is not material?  Or just the unsubstantiated statement from themselves?  
<< Previous
Bullboard Posts
Next >>